CEO and President of Jounce Therapeutics, Inc. (NASDAQ:JNCE), Murray Richard /Ca/, sells 11,816 shares worth $82,712
According to Jounce Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 06:21 AM, company CEO and President, Murray Richard /Ca/ disclosed selling 11,816 shares at a cost of $7.00. At the time of this transaction (Jan 08), this trade was worth $82,712 in total. As of Jan 08, Murray Richard /Ca/ now owns 140,371 shares in total worth about $1,026,112.0099999999.
For the last few recent trades made by Jounce Therapeutics, Inc. (NASDAQ:JNCE) CEO and President, Murray Richard /Ca/, we have the following information:
- SEC Form 4 filing: Jan 07: Sold 10,183 shares at the rate of $6.76 per share. Total worth of this trade was $68,837. Total number of shares owned as of Jan 07 were 152,187
- SEC Form 4 filing: Jan 07: Sold 7,150 shares at the rate of $7.78 per share. Total worth of this trade was $55,627. Total number of shares owned as of Jan 07 were 87,360
- SEC Form 4 filing: Dec 23: Sold 40,000 shares at the rate of $8.37 per share. Total worth of this trade was $334,800. Total number of shares owned as of Dec 23 were 94,510
Posted by
George Daniels
on Monday January 11 2021, 9:46 AM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
